Cardiac surgery for congestive heart failure
Heart failure is a global term for the physiological state in which cardiac output is insufficient for the body's needs. It is a condition in which there is a problem with the structure or function of the heart, which impairs the ability to supply sufficient blood flow to meet the body's needs. Heart failure affects nearly 5.7 million people. Roughly 670,000 people are diagnosed with heart failure each year. It is the leading cause of hospitalization in people with diagnosed heart diseases. If not optimally treated, up to 42% of patients die of HF within 5 years of hospitalization for HF. Sudden cardiac death is 6–9 times more likely in a HF patient as compared to the general population.
Clinical Types
Acute heart failure:
A sudden change in heart function related to some new event that has caused damage to the heart.
Chronic heart failure:
A gradual decline in heart function over a period of time. Often, the body compensates slowly for the loss of heart function.
Causes
Acute Heart Failure
1. Myocardial Infarction
2. Pulmonary Embolism
3. Myocarditis
4. Post-partum Cardiomyopathy
5. Acute worsening of CHF
6. Acute HTx Rejection
7. Trauma
Chronic Heart Failure
8. Coronary artery disease
9. Idiopathic cardiomyopathy
10. Dilated cardiomyopathy
11. Ischemic cardiomyopathy
12. Valvular heart disease
13. Congenital heart disease
Acute Heart Failure – treatment Options
1. IABP - INTRA AORTIC BALLOON PULSATION - acute cardiogenic shock
2. ECMO - EXTRACORPOREAL MEMBRANE OXYGENATION - acute cardiorespiratory failure
IABP: Device placed via the femoral artery (in the leg) to augment coronary blood flow, reduce afterload
ECMO: Blood is removed from the venous system either peripherally via cannulation of a femoral vein or centrally via cannulation of the right atrium, oxygenated, Extract carbon dioxide via membrane oxygenator. Blood is then returned back to the body peripherally via a femoral artery through a Centrifugal pump.
CHF – treatment Options
1. CABG
2. Valve Replacement / Repair Surgery
3. Surgical Ventricular Restoration
4. Restraint Devices
5. Ventricular Assist Devices
6. Total Artificial Heart
7. Heart Transplant
CABG
1. CAD with LV systolic dysfunction
2. CAD suitable for CABG anatomically (TVD, DVD and SVD not suitable for PTCA)
3. Left main CAD ≥ 50% stenosis
4. Class III angina or greater
5. Viable (Hibernating) myocardium–Cardiac MRI/Dobutamine stress echo/ Thallium scan/PET scan
In patients with HF, LVD and CAD amenable to surgical revascularization, CABG added to intensive medical therapy (MED) will decrease all-cause mortality compared to MED alone.
AVR
1.Symptomatic HF in AS/AR
2.Asymptomatic patients with sev AS/AR & EF < 50%.
Ischemic MR is a ventricular problem
• Papillary muscle rupture.
• Stretching/tenting of mitral leaflet
• Alteration in LV geometry, annular dilatation contributes to volume overload, ↑ wall tension, exacerbate failure
Surgery will reverse the cycle of excess ventricular volume, ventricular unloading and promoting myocardial remodeling.
1. Annuloplasty + CABG with chordal shortening/relocation
2. Mitral valve replacement with chordal preservation.
3. Isolated MVR not recommended.
Mitral valve replacement for severe MS/MR, infective endocarditis
Early Sx before severe pulmonary hypertension, LV and RV dysfunction sets in, Outcomes are poor with EF < 30%
Tricuspid valve regurgitation: Can be Functional or Organic with symptoms of right heart failure
Surgical - Tricuspid valve ring annuloplasty
Rare causes
1. Intracardiac tumor
2. Infective endocarditis
3. Pulmonary thromboembolism Acute Chronic
4. Aortic Dissection
5. Aortic Aneurysm
6. GUCH - Grown up congenital heart disease ASD, VSD, TOF, etc. Present usually with severe TR with severe PAH. Eisenmengerization – Inoperable